CTI BIOPHARMA CORP COMMON STOCK (CTIC) Covered Calls

CTI BIOPHARMA CORP COMMON STOCK covered calls Cell Therapeutics, Inc. develops, acquires and commercializes novel treatments for cancer.

You can sell covered calls on CTI BIOPHARMA CORP COMMON STOCK to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CTIC (prices last updated Wed 1:20 PM ET):

CTI BIOPHARMA CORP COMMON STOCK (CTIC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.90 +0.02 1.89 1.90 261K - 0.1B
Covered Calls For CTI BIOPHARMA CORP COMMON STOCK (CTIC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 2 0.01 1.89 0.5% 60.8%
Oct 19 2 0.00 1.90 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.